<?xml version='1.0' encoding='utf-8'?>
<document id="28808272"><sentence text="A combinatorial approach for the discovery of cytochrome P450 2D6 inhibitors from nature." /><sentence text="The human cytochrome P450 2D6 (CYP2D6) enzyme is part of phase-I metabolism and metabolizes at least 20% of all clinically relevant drugs" /><sentence text=" Therefore, it is an important target for drug-drug interaction (DDI) studies" /><sentence text=" High-throughput screening (HTS) assays are commonly used tools to examine DDI, but show certain drawbacks with regard to their applicability to natural products" /><sentence text=" We propose an in silico - in vitro workflow for the reliable identification of natural products with CYP2D6 inhibitory potential" /><sentence text=" In order to identify candidates from natural product-based databases that share similar structural features with established inhibitors, a pharmacophore model was applied" /><sentence text=" The virtual hits were tested for the inhibition of recombinant human CYP2D6 in a bioluminescence-based assay" /><sentence text=" By controlling for unspecific interferences of the test compounds with the detection reaction, the number of false positives were reduced" /><sentence text=" The success rate of the reported workflow was 76%, as most of the candidates identified in the in silico approach were able to inhibit CYP2D6 activity" /><sentence text=" In summary, the workflow presented here is a suitable and cost-efficient strategy for the discovery of new CYP2D6 inhibitors with natural product libraries" /><sentence text="" /></document>